Text Size




Home | Clinical Trials

FDA Approved Drugs » 1996
Medical Areas: Neurology | Oncology | Family Medicine

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names


The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Mallinckrodt Group
Approval Status: Approved August 1996
Treatment Area: chronic pain

General Information

Anexsia has been approved for the treatment of chronic pain. Anexsia is a new dosage strength of medication combining the pain relievers acetaminophen and hydrocodone, an opiate-based narcotic. This new dosage will be the strongest combination of these two analgesics on the market. Anexsia is taken orally and is used to treat moderate to moderately severe pain.

 Back to Top | Printer Friendly Version

Get Involved

Stroke and You

Our Mission Statement

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.

National Stroke Association

9707 E. Easter Lane, Suite B
Centennial, CO 80112